Lifestyle Medical Network (LMNK) 10-Q 2015 Q1 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to _______________

Commission file number 000-52408

LIFESTYLE MEDICAL NETWORK INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada	13-1026995
(State or Other Jurisdiction of	(I.R.S. Employer Identification No.)
Incorporation or Organization)
424 E. Central Blvd., Orlando, FL	32801
(Address of principal executive offices)	(Zip Code)

(407) 514-1230

(Registrant's Telephone Number, Including Area Code)

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. (Check One):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the issuer's common stock, $0.001 par value per share, was 32,084,983 as of June 17, 2015.

LIFESTYLE MEDICAL NETWORK, INC.

INDEX

		Page
Part I.	Financial Information	1
Item 1.	Financial Statements.	1
	Consolidated Balance Sheets as of March 31, 2015 and December 31, 2014 (unaudited)	2
	Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014 (unaudited)	3
	Consolidated Statement of Stockholders’ Equity for the Period through March 31, 2015 (unaudited)	4
	Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014 (unaudited)	5
	Notes to Unaudited Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	15
Item 4.	Controls and Procedures.	15
Part II.	Other Information	15
Item 6.	Exhibits.	15
Signatures		16

PART I — FINANCIAL INFORMATION

ITEM 1.   CONSOLIDATED FINANCIAL STATEMENTS.

Certain information and footnote disclosures required under accounting principles generally accepted in the United States of America have been condensed or omitted from the following consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission. The following unaudited consolidated financial statements should be read in conjunction with the year-end restated consolidated financial statements and notes thereto included in the Company's Form 10-K for the year ended December 31, 2014.

The results of operations for the three months ended March 31, 2015 and 2014 are not necessarily indicative of the results for the entire fiscal year or for any other period.

1

LIFESTYLE MEDICAL NETWORK INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	March 31,			December 31,
	2015			2014
	(Unaudited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	103		$	163
Loan receivable - net of allowance of $42,500		-			-
Deposit on acquisition		100,000			100,000
Prepaid expenses		16,000			16,000
Total Current Assets		116,103			116,163
Property, plant and equipment - net		1,542			1,767
Intangible assets - net		87,504			88,893
TOTAL ASSETS	$	205,149		$	206,823
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
CURRENT LIABILITIES:
Short-term debt to related parties	$	1,050,905		$	1,050,905
Short-term debt		251,000			251,000
Accounts payable and accrued expenses		178,294			127,944
Total Current Liabilities		1,480,199			1,429,849
Commitments and Contingencies		-			-
STOCKHOLDERS' DEFICIENCY:
Common stock, $.001 par value, 200,000,000 shares authorized; 26,085,101 and 26,085,101 shares issued and 26,084,983 and 26,084,983 shares outstanding at March 31, 2015 and December 31, 2014, respectively		26,085			26,085
Additional paid-in-capital		7,315,414			7,295,255
Accumulated deficit		(8,607,312	)		(8,535,129	)
Less: Cost of common stock in treasury, 118 and 118 shares at March 31, 2015 and December 31, 2014, respectively		(9,237	)		(9,237	)
Total Stockholders' Deficiency		(1,275,050	)		(1,223,026	)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$	205,149		$	206,823

See notes to unaudited consolidated financial statements

2

LIFESTYLE MEDICAL NETWORK INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended
	March 31,
	2015			2014
Revenues	$	-		$	-
Costs and expenses:
Selling, general and administrative expenses		62,058			105,455
Total Costs and expenses		62,058			105,455
Loss from operations		(62,058	)		(105,455	)
Other income (expense):
Interest expense		(10,125	)		(27,917	)
Total Other income (expense)		(10,125	)		(27,917	)
Loss from operations before provision for income taxes		(72,183	)		(133,372	)
Provision for income taxes		-			-
Net loss	$	(72,183	)	$	(133,372	)
Loss per common share	$	(0.00	)	$	(0.01	)
Weighted average common shares outstanding
- basic and diluted		26,085,101			25,990,657

See notes to unaudited consolidated financial statements

3

LIFESTYLE MEDICAL NETWORK INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY

(Unaudited)

				Common Stock
				Number of				Additional Paid		Accumulated			Treasury
	Total			Shares		Amount		In Capital		Deficit			Stock
Balance, January 1, 2014	$	(916,604	)		25,835,101	$	25,835	$	7,112,725	$	(8,045,927	)	$	(9,237	)
Issuance of common stock as incentive for debt		25,000			250,000		250		24,750
Amortization of warrants issued for services		157,780							157,780
Net loss for the year ended December 31, 2014		(489,202	)								(489,202	)
Balance, December 31, 2014		(1,223,026	)		26,085,101		26,085		7,295,255		(8,535,129	)		(9,237	)
Amortization of warrants issued for services		20,159							20,159
Net loss for the three months ended March 31, 2015		(72,183	)								(72,183	)
Balance, March 31, 2015	$	(1,275,050	)		26,085,101	$	26,085	$	7,315,414	$	(8,607,312	)	$	(9,237	)

See notes to unaudited consolidated financial statements

4

LIFESTYLE MEDICAL NETWORK INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For The Three Months Ended
	March 31,
	2015			2014
Cash flows from operating activities:
Net loss	$	(72,183	)	$	(133,372	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization		1,390			1,388
Depreciation		225			225
Non-cash compensation		20,158			64,445
Changes in operating assets and liabilities:
Increase in prepaid expenses		-			(4,583	)
Increase(decrease) in accounts payable and accrued expenses		50,350			(7,020	)
Net Cash Used In Operating Activities		(60	)		(78,917	)
Cash flows from investing activities:
Deposit on acquisition		-			(100,000	)
Net Cash Used In Investing Activities		-			(100,000	)
Cash flows from financing activities:
Proceeds from related parties		-			100,000
Proceeds from short-term debt		-			75,000
Net Cash Provided by Financing Activities		-			175,000
Net decrease in cash		(60	)		(3,917	)
Cash and cash equivalents - Beginning of period		163			19,974
Cash and cash equivalents - End of period	$	103		$	16,057

See notes to unaudited consolidated financial statements

5

LIFESTYLE MEDICAL NETWORK INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

AS OF AND FOR THE THREE MONTHS ENDED MARCH 31, 2015 AND 2014

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The consolidated balance sheet as of March 31, 2015 and the consolidated statements of operations, stockholders' deficiency and cash flows for the periods presented have been prepared by Lifestyle Medical Network, Inc. and Subsidiaries (the "Company" or "Lifestyle") and are unaudited. The consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods, and consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' deficiency and cash flows for all periods presented have been made. The information for the consolidated balance sheet as of December 31, 2014 was derived from audited financial statements of the Company.

Organization

Lifestyle Medical Network Inc. and Subsidiaries (the “Company” or “Lifestyle”) was incorporated in the State of Nevada. The Company directs its operations through its subsidiaries. The Company operates its business under a License related to patent rights used in connection with the operations of medical clinics that provide medical services related to men's health, with proprietary trade names and logo designs.

Going Concern

The consolidated financial statements for the period ended March 31, 2015 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company has a past history of recurring losses from operations and is a development stage company. The Company will require additional funding to execute its future strategic business plan. Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure. These factors raise substantial doubt about the Company's ability to continue as a going concern.

The Company has agreed to enter into Management agreements with six medical clinics in Houston, Texas. The Company will provide services to the clinic and will receive an agreed percentage of gross revenues of the practice group. Management intends to make further acquisitions of other medical clinics during 2015.

Management believes these acquisitions will be profitable and the cash flows from these operations will enable the Company to fund the operations of the consolidated group over the next twelve months. Therefore, the annual financial statements continue to be prepared on a going concern basis.

Significant Accounting Policies

The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. There were no significant changes to these accounting policies during the three months ended March 31, 2015 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

2. INTANGIBLES

The MPL License Agreement

The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite Professional IP Licensing, LLC, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men’s health within the territory of the continental United States (the “Licensed Rights”). The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly. The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights.

6

Intangibles are the value of the MPL license. Amounts assigned to this intangible were determined by management. Management considered a number of factors in determining the allocations, including valuations and independent appraisals. The intangibles are being amortized over 19.5 years, the life of the license.

The components of intangible assets are as follows:

License Agreements
Balance January 1, 2011	$	-
Acquisition of license		6,000,000
Amortization for the period May 8, 2011 through December 31, 2011		(200,000	)
Balance December 31, 2011		5,800,000
Amortization for the year ended December 31, 2012		(307,692	)
Impairment charge		(5,392,308	)
Balance December 31, 2012		100,000
Amortization for the year ended December 31, 2013		(5,552	)
Balance December 31, 2013		94,448
Amortization for the year ended December 31, 2014		(5,555	)
Balance December 31, 2014		88,893
Amortization for the three months ended March 31, 2015		(1,389	)
Balance; March 31, 2015	$	87,504

Amortization expense for the three months ended March 31, 2015 and 2014 amounted to $1,389 and $1,389, respectively.

Estimated amortization expense for intangible assets for the next five years is as follows:

Year Ending December 31,		Amortization Expense
	2015	$	4,166
	2016		5,555
	2017		5,555
	2018		5,555
	2019		5,555

7

3. LOAN RECEIVABLE

On February 3, 2012, LMC loaned $32,000 to Health Clinics of Florida, LLC. On April 9, 2012 and August 10, 2012, LMC advanced an additional $10,500. The unsecured notes are interest free and due June 15, 2013. In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default. The manager of Health Clinics of Florida, LLC is a shareholder of the Company. As of December 31, 2012, the Company recorded a reserve for the full amount of the receivable reducing the balance to $-0-.

4. DEBT

Short-term debt as of March 31, 2015 and December 31, 2014 were as follows:

	March 31, 2015		December 31, 2014
Short-term Debt to Related Parties
Unsecured promissory note, interest free, due June 15, 2015 (1)	$	200,000	$	200,000
Unsecured promissory note, interest free, due June 15, 2015 (2)		75,000		75,000
Unsecured promissory note, interest free, due June 15, 2015 (2)		60,000		60,000
Unsecured promissory notes, interest @ 10% per annum, due June 15, 2015 (3)		75,000		75,000
Unsecured promissory notes, interest free due June 15, 2015 (4)		347,200		347,200
Unsecured promissory note, interest free, due June 30, 2015 (5)		193,705		193,705
Unsecured promissory note, interest free, due June 15, 2015 (9)		100,000		100,000
		1,050,905		1,050,905
Less: Current portion		1,050,905		1,050,905
	$	-	$	-

	March 31,		December 31,
	2015		2014
Short-term Debt
Unsecured promissory note, interest free, due on demand (6)	$	26,000	$	26,000
Secured promissory note, interest @ 12% per annum, due December 15, 2015 (7)		150,000		150,000
Unsecured promissory note, interest @ 10%, due December 15, 2015 (8)		75,000		75,000
	$	251,000	$	251,000
Less: Current portion		251,000		251,000
	$	-	$	-

8

(1)	On January 5, 2012, LMC borrowed $200,000 from the Dellinger Fund, a shareholder of the Company. The note is interest free and has been extended to June 15, 2015. In the event of default, the Dellinger Fund has the right to request and will be granted the issuance of two million shares of the Company's common stock.
(2)	On February 3, 2012 and March 1, 2012, LMC borrowed $75,000 and $60,000, respectively, from the Dellinger Fund, a shareholder of the Company. The unsecured notes are interest free and are due June 15, 2015. In the event of default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
(3)	On April 3, 2012, LMC borrowed $75,000 from the Dellinger Fund, a shareholder of the Company. The unsecured note bears interest @ 10% per anum and is due June 15, 2015. In the event of default, interest on the outstanding balance shall continue to accrue at a rate of ten percent (10%) per annum from the date of the default.
(4)	On various dates from March 23, 2012 through November 26, 2012, LMC borrowed $327,200 from the Dellinger Fund, a shareholder of the Company. In February 2013, LMC borrowed an additional $20,000. The unsecured notes are interest free and are due June 15, 2015. In the event of a default, interest on the outstanding balance shall accrue at a rate of ten percent (10%) per annum from the date of the default.
	On April 17, 2015, the Dellinger Fund notes in the amount of $757,200 plus accrued interest were converted into 6,000,000 shares of the Company’s common stock. See Note 11.
(5)	During the year ended December 31, 2013 and 2014, Saddleworth Ventures LLC, a related party, paid expenses amounting to $21,933 and $171,772, respectively, on behalf of the Company. These advances are unsecured, interest free and are due June 30, 2015.
(6)	On May 13, 2013, LMC borrowed $30,000 from Forbes Investment, LLP. The unsecured note is interest free and payable upon demand. In December 2013, LMC repaid $4,000 against the outstanding balance.
(7)	On October 16, 2013, LMC borrowed $150,000 from Edmund Malits, a shareholder of the Company. The secured note bears interest @ 12% per annum and interest and principal are payable in full on or before February 16, 2014. LMC provided the Corporation’s shell on the OTCBB as collateral for the loan. In addition, LMC issued Edmund Malits 500,000 shares of the Company’s common stock with a fair value of $10,000. The note has been extended to December 15, 2015.
(8)	On February 4, 2014, the Company executed an unsecured promissory note with Curt Maes and received $75,000. The promissory note bears interest @ 10% per annum and both principal and interest are payable on or before December 15, 2015. As additional consideration, the Company issued Curt Maes 250,000 shares of the Company’s common stock valued @ $25,000.
(9)	In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due April 15, 2015. Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company’s common stock at a price of $0.10 per share. On April 10, 2015, the note was repaid in full. See Note 11.

Interest expense for the three months ended March 31, 2015 and 2014 amounted to $10,125 and $27,917, respectively.

5. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

	March 31, 2015		December 31, 2014
Interest	$	57,275	$	47,150
Salaries - Officer		35,000		20,000
Professional fees		79,026		56,421
Other		6,994		4,373
	$	178,295	$	127,944

9

6. INCOME TAXES

The Company adopted the provisions of ASC 740, "Income Taxes", ("ASC 740"). As a result of the implementation of ASC 740, the Company recognized no adjustment in the net liability for unrecognized income tax benefits. The Company believes there are no potential uncertain tax positions and all tax returns are correct as filed. Should the Company recognize a liability for uncertain tax positions, the Company will separately recognize the liability for uncertain tax positions on its balance sheet. Included in any liability for uncertain tax positions, the Company will also setup a liability for interest and penalties. The Company’s policy is to recognize interest and penalties related to uncertain tax positions as a component of the current provision for income taxes.

There is no U.S. tax provision due to losses from U.S. operations during the three months ended March 31, 2015 and 2014. Deferred income taxes are provided for the temporary differences between the financial reporting and tax basis of the Company's assets and liabilities. The principal item giving rise to deferred taxes is the net operating loss carryforward in the U.S. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has set up a valuation allowance for losses for certain carryforwards that it believes may not be realized.

Section 382 of the U.S. Internal Revenue Code imposes an annual limitation on the availability of NOL carryforwards to offset taxable income when an ownership change occurs. The Company's reverse capitalization meets the definition of an ownership change and some of the NOL's will be limited.

7. STOCKHOLDERS' EQUITY

On February 4, 2014, the Company issued Curt Maes 250,000 shares of the Company’s common stock with a fair value of $25,000 as incentive for debt financing.

8. WARRANTS

On February 6, 2012, the Company issued warrants as compensation to a third party to purchase 2,400,000 shares of the Company's common stock for services performed. The warrants expire February 6, 2017. The estimated value of the compensatory warrants was determined using the Black Scholes pricing model using the following assumptions: Expected term of 3 years, a risk free interest rate of 0.32%, a dividend yield of -0-% and volatility of 432%. The fair value of the warrant amounted to $479,912 to be amortized over 3 years. The Company recorded an expense of $20,159 and $39,445 on the Company’s consolidated statement of operations for the three months ended March 31, 2015 and 2014, respectively.

The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company. The warrants were granted in lieu of cash compensation for services performed.

	Shares		Weighted Average Exercise Price		Remaining Life	Intrinsic Value
Outstanding, January 1, 2015		2,400,000	$	0.20
Granted		-		-
Expired/Cancelled		-		-
Exercised		-		-
Outstanding - period ending March 31, 2015		2,400,000	$	0.20	2.1 years	$	-
Exercisable - period ending March 31, 2015		2,400,000	$	0.20	2.1 years	$	-

9. RELATED PARTY TRANSACTIONS

a) During the years ended December 31, 2014 and 2013, Saddleworth Ventures LLC paid expenses amounting to $21,933 and $171,772, respectively, on behalf of the Company. These advance are unsecured, interest free and due June 30, 2015. As of March 31, 2015, no repayments have been made.

b) During the year ended December 31, 2012, the Company received $737,200 in advances from the Dellinger Fund, a shareholder of the Company. During the year ended December 31, 2013, the Dellinger Fund advanced an additional $20,000. The majority of these advances are interest free. The Company recorded interest expense for the three months ended March 31, 2015 and 2014 in the amount of $1,875 and $1,875, respectively, on the advances that were not interest free. See Note 4 for further information.  

c) In February 2014, the Company received from Saddleworth Ventures an advance of $100,000 that was used as an initial down payment for an acquisition. The advance is interest free and due June 15, 2015. Saddleworth Ventures has the option to convert the note representing the advance, in whole or in part, into shares of the Company’s common stock at a price of $0.10 per share. See Note 4 for further information.

10

10. COMMITMENTS AND CONTINGENCIES

Consulting Agreements

a) In January 2012, Lifestyle entered into a consulting agreement with Saddleworth Ventures LLC ("Consultant"). The Consultant will provide services for management consulting, business advisory, shareholder information and public relations. The term of the agreement is for three years. Upon execution of the agreement, Lifestyle issued a payment to the Consultant in the amount of $25,000. Additional cash fees or reimbursement of expenses shall be agreed upon by Lifestyle and the Consultant from time to time during the term of the agreement. Consulting fees for the three months ended March 31, 2015 and 2014 amounted to $-0- and $-0-, respectively.

b) During 2014, 2013 and 2012, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services. For the three months ended March 31, 2015 and 2014, consulting services amounted to $-0- and $12,500, respectively.

c) On July 1, 2012, Lifestyle entered into an employment agreement with Christopher Smith ("Smith"), the Company's Chief Executive Officer. The term of the agreement is for five years. Lifestyle will pay Smith minimum compensation of $60K per year. Smith will also receive a performance bonus based on a percentage of the Company's net operating profit before income taxes. For the three months ended March 31, 2015, and 2014, payroll-officer amounted to $15,000 and $15,000, respectively.

11. SUBSEQUENT EVENTS

Material Agreements

Dr. Ronald Moomaw, a director of the Company and a licensed physician in the State of Texas, who had been assisting the Company in evaluating the acquisition by the Company of two medical practices in Houston, Texas, has purchased the two medical professional associations, MED-CURE Primary Care Physicians, P.A. and MED-CURE Anti-Aging and Skin Care, P.A. (the “MED-CURE Companies”), effective April 1, 2015. The MED-CURE Companies were purchased by Dr. Moomaw directly from the owner, Dr. Nazmudin Keshwani, for a purchase price of $2,500,000, utilizing local bank financing.

The MED-CURE Companies between them operate six medical clinics in Houston, of which four are primary care clinics and two are skin care clinics. Dr. Keshwani has entered into employment contracts extending through December 31, 2015, with the MED-CURE Companies as a “physician employee”, pursuant to which he will perform medical services as are required for operations of the clinics. The MED-CURE Companies have agreed to enter into management agreements with the Company which will be effective as of April 1, 2015, pursuant to which the Company, through its subsidiary Lifestyle Texas Medical Management, LLC (“Lifestyle Management”), will provide organizational development, accounting, human resources, computer technical support compliance, scheduling, marketing and advertising, office space, equipment supplies and other management services and will receive an agreed percentage of the gross revenues of the practice group, with adjustments designed to ensure that management fees do not exceed an agreed cap, or that the remaining amounts distributed to the doctors are no less than a specified floor percentage of gross revenues.

Through our subsidiary, Regional Professional Alliance, Inc. , a physician’s professional consulting company that provides professional medical consulting services to medical management companies related to matters affecting professional licensure and medical clinic compliance matters for the benefit of clinics managed by Lifestyle Management, we have agreed to enter into a Regional Medical Director Agreement, which will be effective as of April 1, 2015, with Dr. Moomaw, pursuant to which Lifestyle Professional Alliance would provide the services of Dr. Moomaw for the benefit of Lifestyle Management related to oversight and professional medical services coordination of the managed clinics which have entered into management services agreements with Lifestyle Management.

11

Through Lifestyle Texas Licensing, LLC (“Lifestyle Licensing”), the Company plans to sublicense to the MED-CURE Companies the non-exclusive right to use, and to sublicense the use of, certain patents, trademarks, trade names, service marks, logos, slogans, trade dress, commercial symbols, operational systems, and other intellectual property rights, in connection with operating and managing medical clinics that provide medical services and/or products of a distinctive character and quality, in particular relating to men’s health.

Issuance of Warrants

In connection with the engagement of our director, Dr. Ronald Moomaw, under a Regional Medical Director Agreement with RPA, at a Board of Directors meeting, held on April 17, 2015, the Board authorized the issuance Dr. Moomaw of a seven year stock purchase warrant, expiring April 17, 2022, to purchase 5,000,000 shares of our common stock, at an exercise price of $.09 per share, valued at $465,000.

.

Conversion of Debt

At the Board meeting held on April 17, 2015, our Board approved the conversion by the Company of $757,200 principal amount plus accrued interest of Company debt held by The Dellinger Fund, into an aggregate of 6,000,000 shares of common stock.

Refund of Deposit

On April 10, 2015, the Company received from Dr. Nazmudin Keshwani a refund of the $100,000 deposit made by the Company in February 14, 2014, in connection with the Company’s previous negotiations to acquire the MED-CURE Companies.

Convertible Promissory Note

On April 28, 2015, the Company issued a convertible promissory note to Ray Meadow and received proceeds of $250,000. The promissory note bears interest @ 12% per anum and matures one year from the date of issuance. At any time, the holder of the note, at his sale option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company at a conversion price of $0.15 per share, the fair value of the common stock at the date of the advance.

12

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and notes thereto and the other financial information included elsewhere in this report.  Certain statements contained in this report, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Such forward-looking statements involve known and unknown risks and uncertainties.  Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity; and international, national and local general economic and market conditions.

Organization

The Company was incorporated in the State of Nevada on September 3, 2003, under the name Beverly Hills Film Studios, Inc. and changed its name to Emerging Media holdings, Inc. on September 28, 2006. On September 30, 2006, we effectuated a share exchange whereby we acquired all of the outstanding equity interests in our wholly-owned subsidiary, IM “Media Alianta” SRL, the 100% owner of SA “Analiticmedia-Grup”, both Moldovan companies ("AMG"), and on May 2, 2008, the Company acquired the common stock of “TNT-Bravo” channel-ICS “Media Top Prim” SRL, the exclusive operator in Moldova of Russian channel TNT programs owned by Gazprom Media.

On July 11, 2012, through a merger with our wholly-owned Nevada subsidiary, Lifestyle Medical Network Inc., the name of our Company was changed from Emerging Media Holdings, Inc. to Lifestyle Medical Network Inc.  The change of our corporate name was approved by FINRA, effective for trading purposes on July 31, 2012.

Acquisition of Lifestyle Medical Corp.

On December 29, 2011, we closed an acquisition of 100% of the outstanding shares of Lifestyle Medical Corp. (“Lifestyle Medical”), which has rights to technologies and practices licensed to its subsidiary, Elite Professional IP Licensing, LLC (“Elite”), pursuant to an October 5, 2010 License Agreement with Modular Properties Limited, Inc. (the “License Agreement”). The consideration paid by the Company for the acquisition of Lifestyle Medical was 5,000,000 shares of our common stock paid to the holders of a majority of the outstanding shares of LMC, valued at $2,500,000. On February 2, 2012, we completed acquisition of the rights to our licensed men’s medical clinic operating technologies and processes, by acquiring from Worldwide Medassets, Ltd. (SAL) the full assignment of rights to the License Agreement, by the issuance of 19,000,000 shares of our common stock in exchange for the satisfaction of the outstanding $3,000,000 principal balance on the note issued to Worldwide Medassets, Ltd. in connection with the assignment of rights to the License Agreement to Elite.

On December 29, 2011, we completed the sale of our remaining Moldova media subsidiaries in exchange for the assumption of the liabilities of the subsidiaries and 250,000 shares of our common stock.

Recent Developments

We have entered into management agreements with two medical professional associations located in Houston, Texas, MED-CURE Primary Care Physicians, P.A. and MED-CURE Anti-Aging and Skin Care, P.A. (the “MED-CURE Companies”), effective April 1, 2015, which were purchased by Dr. Ronald Moomaw, a director of the Company. The MED-CURE Companies between them operate six medical clinics in Houston, of which four are primary care clinics and two are skin care clinics. The MED-CURE Companies have agreed, effective April 1, 2015, to enter into management agreements with the Company, pursuant to which the Company, through its subsidiary Lifestyle Texas Medical Management, LLC (“Lifestyle Management”), will provide organizational development, accounting, human resources, computer technical support compliance, scheduling, marketing and advertising, office space, equipment supplies and other management services and will receive an agreed percentage of the gross revenues of the practice group, with adjustments designed to ensure that management fees do not exceed an agreed cap, or that monthly payments do not result in an event of default under the acquisition financing documents for the MED-CURE Companies. The leasing arrangements for the properties leased for the MED-CURE Companies’ clinics’ offices were restructured, with our real estate subsidiary, Lifestyle Texas Real Estate, LLC, leasing the properties and then subleasing the properties back to the Med-Cure Companies.

Through our subsidiary, Regional Professional Alliance, Inc., a physician’s professional consulting company that provides professional medical consulting services to medical management companies related to matters affecting professional licensure and medical clinic compliance matters for the benefit of clinics managed by Lifestyle Management, we have entered into an agreement with Dr. Moomaw to provide services through Regional Professional Alliance for the benefit of Lifestyle Management related to oversight and professional medical services coordination of the managed clinics which have entered into management services agreements with Lifestyle Management. Through Lifestyle Texas Licensing, LLC (“Lifestyle Licensing”), the Company plans to sublicense to the MED-CURE Companies the non-exclusive right to use, and to sublicense the use of, certain patents, trademarks, trade names, service marks, logos, slogans, trade dress, commercial symbols, operational systems, and other intellectual property rights, in connection with operating and managing medical clinics that provide medical services and/or products of a distinctive character and quality, in particular relating to men’s health and weight management.

13

Throughout this Form 10-Q, the terms "we," "us," "our," "LMN" and the "Company" refer to Lifestyle Medical Network Inc., a Nevada corporation, and unless the context indicates otherwise, includes our subsidiaries.

Critical Accounting Policies and Estimates

The discussion and analysis of our plan of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect our reported results of operations and the amount of reported assets and liabilities.

Some accounting policies involve judgments and uncertainties to such an extent that there is reasonable likelihood that materially different amounts could have been reported under different conditions, or if different assumptions had been used. Actual results may differ from the estimates and assumptions used in the preparation of our consolidated financial statements.

The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.  There were no significant changes to these accounting policies during the three months ended March 31, 2015, and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

PLAN OF OPERATION

Through our consulting subsidiaries, we plan to contract to provide management and professional consulting services, and to license medical and health technologies, to medical and health clinic operating companies. We also we intend to open, operate and acquire men’s medical and health clinics, if financing is available and the profile of the clinics’ services is consistent with the types of medical businesses we view as favorable for acquisition.

RESULTS OF OPERATIONS

THREE MONTHS ENDED MARCH 31, 2015 COMPARED TO THE THREE MONTHS ENDED MARCH 31, 2014

During the three months ended March 31, 2015, we incurred a net loss of $72,183, compared to a loss of $133,372 for the three months ended March 31, 2014.  The decrease in the loss is primarily due to a decrease of approximately $43,000 in general and administrative expense, primarily consulting fees and amortization, and a decrease of approximately $16,000 in interest expense due to the issuance of shares in connection with the origination of a loan that increased interest expense in 2014.

LIQUIDITY AND FINANCIAL RESOURCES

At March 31, 2015, we had a working capital deficiency of approximately $1.4 million.  At March 31, 2015, we had total assets of approximately $205,000, including cash of $103. Net cash used in operating activities in the three months ended March 31, 2015 was $60, primarily from the net loss of approximately $72,000, offset by an increase in accounts payable of $50,000 and non-cash compensation of approximately $20,000.

We may continue to incur operating losses in the future. In the first three months of 2015, we had $-0- of revenues, operating expenses of $62,058, and no net income.  As of March 31, 2015, we had $103 cash on hand to fund operations.  There is no assurance that we will operate profitably in the future.

In April 2015, we obtained interim capital through a $250,000 loan, evidenced by a 12% Promissory Note with a principal amount of $250,000, and a $100,000 loan, evidenced by a 10% Promissory Note due April 27, 2016, and return of a deposit payment of $100,000. We will have to obtain significant additional capital to continue with our medical facility management business.

There is no assurance that we will be able to obtain sufficient capital to implement our business plans. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  These conditions and uncertainties raise substantial doubt about the Company's ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

14

Off Balance Sheet Arrangements

We do not currently have any off balance sheet arrangements falling within the definition of Item 303(c) of Regulation S-B.

Inflation

To date inflation has not had a material impact on our operations.

ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

ITEM 4.    Controls and Procedures.

As of March 31, 2015, the end of the period covered by this quarterly report, the Chief Executive and Chief Financial Officer of the Company (the “Certifying Officer”) conducted an evaluation of the Company’s disclosure controls and procedures.  As defined under Sections 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officer, to allow timely decisions regarding required disclosure.

Based on this evaluation, the Certifying Officer has concluded that the Company’s disclosure controls and procedures were not effective for the quarter ended March 31, 2015, to ensure that material information is recorded, processed, summarized and reported by management of the Company on a timely basis in order to comply with the Company’s disclosure obligations under the Exchange Act, and the rules and regulations promulgated there under.

Further, there were no changes in the Company’s internal control over financial reporting during the first fiscal quarter of our 2014 fiscal year that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II

Other Information

Item 6.    Exhibits.

31	Certification of Chief Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)
32	Certification of Chief Executive Officer and Principal Financial Officer  pursuant to 18 U.S.C. Section 1350

Copies of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K.

SEC Ref. No.	Title of Document
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

The XBRL related information in Exhibits 101 to this Quarterly Report on Form 10-Q shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and is not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of those sections.

15

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	LIFESTYLE MEDICAL NETWORK INC. (Registrant)
Date:   June 17, 2015	By:	/s/ Christopher Smith
		Christopher Smith, Chief Executive Officer and Principal Financial Officer

16